• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Jade Biosciences, Inc. - Common Stock (NQ:JBIO)

    9.140 +0.050 (+0.55%)
    Streaming Delayed Price Updated: 3:32 PM EDT, Oct 14, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Jade Biosciences, Inc. - Common Stock

    Jade Biosciences Announces JADE201, a Potentially Best-in-Class Half-Life Extended Afucosylated Anti-BAFF Receptor Monoclonal Antibody in Development for Autoimmune Diseases
    From Jade Biosciences
    Via GlobeNewswire
    Jade Biosciences Announces $135 Million Private Placement
    From Jade Biosciences
    Via GlobeNewswire
    12 Health Care Stocks Moving In Wednesday's After-Market Session
     
    Via Benzinga
    Jade Biosciences Announces First Cohort Dosed in Phase 1 Healthy Volunteer Clinical Trial of JADE101, a Novel and Potentially Best-in-Class Anti-APRIL Monoclonal Antibody Being Evaluated for the Treatment of IgA Nephropathy
    From Jade Biosciences
    Via GlobeNewswire
    Jade Biosciences to Participate in Upcoming Conferences
    From Jade Biosciences
    Via GlobeNewswire
    Jade Biosciences Posts Wider Loss in Q2
    Via The Motley Fool
    Jade Biosciences Reports Second Quarter 2025 Financial Results and Provides Corporate Update
    From Jade Biosciences
    Via GlobeNewswire
    Abbott Laboratories Issues Weak Earnings Forecast, Joins MP Materials And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
     
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
     
    Via Benzinga
    Why Sarepta Therapeutics Shares Are Trading Higher By 34%; Here Are 20 Stocks Moving Premarket
     
    Via Benzinga
    Jade Biosciences to Participate in Two Upcoming Investor Conferences
    From Jade Biosciences
    Via GlobeNewswire
    Jade Biosciences Appoints Brad Dahms as Chief Financial Officer
    From Jade Biosciences
    Via GlobeNewswire
    12 Health Care Stocks Moving In Monday's Pre-Market Session
     
    Via Benzinga
    Jade Biosciences Presents JADE101 Preclinical Data at the 62nd European Renal Association Congress Demonstrating Potential for Best-in-Class Profile in IgA Nephropathy
    From Jade Biosciences
    Via GlobeNewswire
    Jade Biosciences to Present New Preclinical Data on JADE101 at the 62nd European Renal Association Congress
    Company to host conference call and webcast on June 9, 2025, at 8:00 a.m. ET 
    From Jade Biosciences
    Via GlobeNewswire
    Jade Biosciences Reports First Quarter 2025 Financial Results and Provides Corporate Update
    From Jade Biosciences
    Via GlobeNewswire
    Jade Biosciences to Participate in the 2025 Jefferies Global Healthcare Conference
    From Jade Biosciences
    Via GlobeNewswire
    Expedia, Wolfspeed, HubSpot And Other Big Stocks Moving Lower In Friday's Pre-Market Session
     
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
     
    Via Benzinga
    Why Pinterest Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
     
    Via Benzinga
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.